A number of investment brokers have recently updated their price targets on shares of AxoGen, Inc. (AXGN).

Most recent broker ratings

11/06/2015 – AxoGen, Inc. had its “market outperform” rating reiterated by analysts at JMP Securities. They now have a USD 8 price target on the stock.

08/27/2015 – AxoGen, Inc. had its “outperform” rating reiterated by analysts at Wedbush. They now have a USD 5 price target on the stock.

04/04/2015 – AxoGen, Inc. had its “neutral” rating reiterated by analysts at Ladenburg Thalmann. They now have a USD 3.75 price target on the stock.

04/01/2015 – AxoGen, Inc. was downgraded to “hold” by analysts at Langenberg & Company.

01/19/2015 – AxoGen, Inc. was downgraded to “neutral” by analysts at Zacks. They now have a USD 4.5 price target on the stock.

11/25/2014 – Lake Street began new coverage on AxoGen, Inc. giving the company a “buy” rating. They now have a USD 4 price target on the stock.

05/14/2014 – Dawson James began new coverage on AxoGen, Inc. giving the company a “buy” rating. They now have a USD 5 price target on the stock.

The share price of AxoGen, Inc. (AXGN) was down -0.18% during the last trading session, with a day high of 5.80. 44623 shares were traded on AxoGen, Inc.’s last session.

The stock’s 50 day moving average is 5.43 and its 200 day moving average is 5.14. The stock’s market capitalization is 169.41M. AxoGen, Inc. has a 52-week low of 2.95 and a 52-week high of 6.08.

View other investors thoughts on AxoGen, Inc. with our new Stock Talk discussion platform. Sign up for free to contribute to the community and view research provided from other investors for any stock listed on the LSE, NYSE or NASDAQ.